Cargando…

Tumor microenvironment and immunotherapy of oral cancer

Oral cancer is one of the most common malignant tumors of the head and neck, not only affects the appearance, but also affects eating and even endangers life. The clinical treatments of oral cancer mainly include surgery, radiotherapy, and chemotherapy. However, unsatisfactory therapeutic effect and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Wang, Min, Zhang, Haiyang, Li, Chunyan, Zhang, Tianshou, Liu, Hong, Zhu, Song, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547678/
https://www.ncbi.nlm.nih.gov/pubmed/36209263
http://dx.doi.org/10.1186/s40001-022-00835-4
_version_ 1784805316160913408
author Liu, Chang
Wang, Min
Zhang, Haiyang
Li, Chunyan
Zhang, Tianshou
Liu, Hong
Zhu, Song
Chen, Jie
author_facet Liu, Chang
Wang, Min
Zhang, Haiyang
Li, Chunyan
Zhang, Tianshou
Liu, Hong
Zhu, Song
Chen, Jie
author_sort Liu, Chang
collection PubMed
description Oral cancer is one of the most common malignant tumors of the head and neck, not only affects the appearance, but also affects eating and even endangers life. The clinical treatments of oral cancer mainly include surgery, radiotherapy, and chemotherapy. However, unsatisfactory therapeutic effect and toxic side effects are still the main problems in clinical treatment. Tumor microenvironment (TME) is not only closely related to the occurrence, growth, and metastasis of tumor but also works in the diagnosis, prevention, and treatment of tumor and prognosis. Future studies should continue to investigate the relationship of TME and oral cancer therapy. This purpose of this review was to analyze the characteristics of oral cancer microenvironment, summarize the traditional oral cancer therapy and immunotherapy strategies, and finally prospect the development prospects of oral cancer immunotherapy. Immunotherapy targeting tumor microenvironment is expected to provide a new strategy for clinical treatment of oral cancer.
format Online
Article
Text
id pubmed-9547678
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95476782022-10-10 Tumor microenvironment and immunotherapy of oral cancer Liu, Chang Wang, Min Zhang, Haiyang Li, Chunyan Zhang, Tianshou Liu, Hong Zhu, Song Chen, Jie Eur J Med Res Review Oral cancer is one of the most common malignant tumors of the head and neck, not only affects the appearance, but also affects eating and even endangers life. The clinical treatments of oral cancer mainly include surgery, radiotherapy, and chemotherapy. However, unsatisfactory therapeutic effect and toxic side effects are still the main problems in clinical treatment. Tumor microenvironment (TME) is not only closely related to the occurrence, growth, and metastasis of tumor but also works in the diagnosis, prevention, and treatment of tumor and prognosis. Future studies should continue to investigate the relationship of TME and oral cancer therapy. This purpose of this review was to analyze the characteristics of oral cancer microenvironment, summarize the traditional oral cancer therapy and immunotherapy strategies, and finally prospect the development prospects of oral cancer immunotherapy. Immunotherapy targeting tumor microenvironment is expected to provide a new strategy for clinical treatment of oral cancer. BioMed Central 2022-10-08 /pmc/articles/PMC9547678/ /pubmed/36209263 http://dx.doi.org/10.1186/s40001-022-00835-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Liu, Chang
Wang, Min
Zhang, Haiyang
Li, Chunyan
Zhang, Tianshou
Liu, Hong
Zhu, Song
Chen, Jie
Tumor microenvironment and immunotherapy of oral cancer
title Tumor microenvironment and immunotherapy of oral cancer
title_full Tumor microenvironment and immunotherapy of oral cancer
title_fullStr Tumor microenvironment and immunotherapy of oral cancer
title_full_unstemmed Tumor microenvironment and immunotherapy of oral cancer
title_short Tumor microenvironment and immunotherapy of oral cancer
title_sort tumor microenvironment and immunotherapy of oral cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547678/
https://www.ncbi.nlm.nih.gov/pubmed/36209263
http://dx.doi.org/10.1186/s40001-022-00835-4
work_keys_str_mv AT liuchang tumormicroenvironmentandimmunotherapyoforalcancer
AT wangmin tumormicroenvironmentandimmunotherapyoforalcancer
AT zhanghaiyang tumormicroenvironmentandimmunotherapyoforalcancer
AT lichunyan tumormicroenvironmentandimmunotherapyoforalcancer
AT zhangtianshou tumormicroenvironmentandimmunotherapyoforalcancer
AT liuhong tumormicroenvironmentandimmunotherapyoforalcancer
AT zhusong tumormicroenvironmentandimmunotherapyoforalcancer
AT chenjie tumormicroenvironmentandimmunotherapyoforalcancer